During the past decade, South Texas Oncology and Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Texas Oncology and Hematology" #1 sponsor was "SCRI Development Innovations, LLC" with 7 trials, followed by "Morphotek" with 2 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Pancreatic Cancer Research Team" with 2 trials sponsored and "Aronex Pharmaceuticals" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Oncology and Hematology" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "South Texas Oncology and Hematology" are "Breast Cancer" (3 trials), "Metastatic Pancreatic Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Pancreas Cancer" (2 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "South Texas Oncology and Hematology" in a lesser frequency.

Most popular intervention types in "South Texas Oncology and Hematology" are "Drug" (24 trials), "Biological" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (4 trials), "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials), "Radiation Therapy" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Texas Oncology and Hematology" are 20 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "South Texas Oncology and Hematology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in South Texas Oncology and Hematology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in South Texas Oncology and Hematology, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".